Tag: Pharmacokinetics
-
Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma
Conditions: Asthma; Moderate AsthmaInterventions: Drug: REGN3500; Drug: PlaceboSponsors: Regeneron Pharmaceuticals; SanofiNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 (Rhizen Pharmaceuticals 3128)
Conditions: Healthy Volunteers; AsthmaInterventions: Drug: RP3128; Drug: PlaceboSponsor: Rhizen Pharmaceuticals SARecruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.
Condition: Asthma, Chronic Obstructive Pulmonary Disease (COPD)Interventions: Drug: Treatment A – AZD7594; Drug: Treatment B – AZD7594; Drug: Treatment C – AZD7594Sponsor: AstraZenecaNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.
Condition: Asthma, Chronic Obstructive Pulmonary Disease (COPD)Interventions: Drug: Treatment A – AZD7594; Drug: Treatment B – AZD7594; Drug: Treatment C – AZD7594Sponsor: AstraZenecaNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men
Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)Interventions: Drug: AZD7594 inhalation powder (200 ?g); Drug: AZD7594 inhalation powder (400 ?g); Drug: AZD7594 pressurized inhalation suspension (200 ?g); Drug: AZD7594 placebo inhalation powder; Drug: AZD7594 placebo pressurized inhalation suspensionSponsor: AstraZenecaNot yet recruiting – verified December 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma
Condition: AsthmaInterventions: Drug: CVT-301 (levodopa inhalation powder); Drug: Carbidopa; Other: PlaceboSponsor: Acorda TherapeuticsRecruiting – verified December 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
Clinical Study to Evaluate Z7200 Pharmacokinetics Profile
Condition: AsthmaInterventions: Drug: Z7200; Drug: Symbicort Turbohaler; Drug: Z7200 with charcoal; Drug: Symbicort Turbohaler with charcoal; Drug: Symbicort Turbohaler replicateSponsor: Zambon SpANot yet recruiting – verified December 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma
Condition: AsthmaIntervention: Drug: MEDI9929 (AMG 157)Sponsors: MedImmune LLC; AmgenNot yet recruiting – verified July 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older
Condition: AsthmaInterventions: Drug: Treatment A: Fp MDPI; Drug: Treatment B: FS MDPI; Drug: Treatment C Flovent; Drug: Treatment D: AdvairSponsor: Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified May 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
Condition: AsthmaIntervention: Drug: MepolizumabSponsor: GlaxoSmithKlineNot yet recruiting – verified February 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days